|
(2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)phenyl)methanamine
|
|
1821248-00-3
|
|
NE10790
|
|
152831-36-2
|
|
FLT3-IN-3
|
|
2229050-90-0
|
|
WAY-181187 hydrochloride
|
|
554403-08-6
|
|
4-[2-(2,6-dioxo-3-piperidinyl)-6-fluoro-2,3-dihydro-1,3-dioxo-1Hisoindol-5-yl]-, 1,1-dimethylethyl ester-1-Piperazinecarboxylic acid
|
|
2222116-02-9
|
|
PBD dimer
|
PBD-二聚体
|
1222490-34-7
|
|
Phentolamine Analogue 1
|
|
47142-51-8
|
|
Apixaban Impurity 38
|
阿哌沙班杂质38
|
1802522-36-6
|
|
TY-52156
|
|
934369-14-9
|
|
6-Cyclopropyl-1-isopropyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid
|
6-环丙基-1-异丙基-1H-吡唑并[3,4-B]吡啶-4-羧酸
|
851288-57-8
|
|
Ebastine Impurity G
|
依巴斯汀杂质G
|
1429071-65-7
|
|
Budesonide Impurity 7
|
布地奈德杂质7
|
3949-79-9
|
|
UNC6934
|
|
2561494-77-5
|
|
Ebastine Impurity F
|
依巴斯汀杂质F
|
1429071-63-5
|
|
TBI-166
|
|
1353734-12-9
|
|
Daunomycinone
|
柔红酮
|
21794-55-8
|
|
CR8, (R)-Isomer
|
|
294646-77-8
|
|
FIDAS-3
|
|
1266684-01-8
|
|
BMS-986176
|
|
1815613-42-3
|
|
(R)-CR8 trihydrochloride
|
|
1786438-30-9
|
|
SJ-172550
|
|
431979-47-4
|
|
Ibalizumab
|
伊巴组单抗
|
680188-33-4
|
|
Otelixizumab
|
奥昔组单抗
|
881191-44-2
|
|
Tigatuzumab
|
替加组单抗
|
918127-53-4
|
|
Panobacumab
|
帕巴库单抗
|
885053-97-4
|
|
NVR-3-778
|
|
1445790-55-5
|
|
I-BET567
|
|
1887237-54-8
|
|
Raxibacumab
|
雷昔库单抗
|
565451-13-0
|
|
Tefibazumab
|
替非组单抗
|
521079-87-8
|
|
Yttrium (90Y) Tacatuzumab Tetraxetan
|
钇[90Y]替组单抗(97)
|
476413-07-7
|
|
Bapineuzumab
|
巴匹组单抗
|
648895-38-9
|
|
Pagibaximab
|
帕昔单抗
|
595566-61-3
|
|
Sontuzumab
|
索土珠单抗
|
372075-37-1
|
|
Iratumumab
|
伊妥木单抗
|
640735-09-7
|
|
Disitamab Vedotin
|
纬迪西妥单抗
|
2136633-23-1
|
|
Edrecolomab
|
依决洛单抗
|
156586-89-9
|
|
Libivirumab
|
利韦单抗
|
569658-79-3
|
|
7-O-(Triethylsilyl) Baccatin III
|
7-O-(三乙基硅烷)巴卡汀III
|
115437-21-3
|
|
GSK 2033
|
|
1221277-90-2
|
|
Besilesomab
|
贝索单抗
|
537694-98-7
|
|
Volociximab
|
伏洛昔单抗
|
558480-40-3
|
|
BVT948
|
|
39674-97-0
|
|
HLY78
|
|
854847-61-3
|
|
Exbivirumab
|
艾韦单抗
|
569658-80-6
|
|
elsilimomab
|
艾西莫单抗
|
468715-71-1
|
|
Oxelumab
|
奥塞芦单抗
|
1186098-83-8
|
|
Rilotumumab
|
利妥木单抗
|
872514-65-3
|
|
SIS3
|
|
1009104-85-1
|
|
YH53
|
|
1471484-62-4
|
|
RGD Trifluoroacetate
|
|
2378808-45-6
|
|
EIT hydrobromide
|
|
1071-37-0
|
|
Robatumumab
|
罗妥木单抗
|
934235-44-6
|
|
Teneliximab
|
替奈昔单抗
|
395639-53-9
|
|
Pritumumab
|
普林木单抗
|
499212-74-7
|
|
Elotuzumab
|
依妥组单抗
|
915296-00-3
|
|
Anatumomab
|
安那莫单抗
|
|
|
Vapaliximab
|
伐利昔单抗
|
336801-86-6
|
|
Reslizumab
|
瑞利珠单抗
|
241473-69-8
|
|
Ecromeximab
|
依美昔单抗
|
292819-64-8
|
|
Erlizumab
|
厄利珠单抗
|
211323-03-4
|
|
Figitumumab
|
芬妥木单抗
|
943453-46-1
|
|
Farletuzuma
|
法妥组单抗
|
896723-44-7
|
|
Cixutumumab
|
西妥木单抗
|
947687-12-9
|
|
Lemalesomab
|
来马索单抗
|
250242-54-7
|
|
Sibrotuzumab
|
西罗珠单抗
|
216669-97-5
|
|
Bivatuzumab
|
比伐珠单抗
|
|
|
Olokizumab
|
奥拉单抗
|
1007223-17-7
|
|
Foralumab
|
福雷芦单抗
|
946415-64-1
|
|
Drozitumab
|
曲齐妥单抗
|
912628-39-8
|
|
Itolizumab
|
伊利组单抗
|
1116433-11-4
|
|
Ensituximab
|
恩妥昔单抗
|
1092658-06-4
|
|
Teprotumumab
|
替妥木单抗
|
1036734-93-6
|
|
Glembatumumab
|
格巴妥木单抗
|
1020264-78-1
|
|
Lebrikizumab
|
来瑞组单抗
|
953400-68-5
|
|
Fezakinumab
|
非扎奴单抗
|
1007106-86-6
|
|
Suvizumab
|
舒维组单抗
|
914257-21-9
|
|
Girentuximab
|
吉妥昔单抗
|
916138-87-9
|
|
Rontalizumab
|
隆利组单抗
|
948570-30-7
|
|
Dalotuzumab
|
达罗托组单抗
|
1005389-60-5
|
|
Mavrilimumab
|
玛弗利木单抗
|
1085337-57-0
|
|
Sifalimumab
|
西法木单抗
|
1006877-41-3
|
|
Intetumumab
|
英妥木单抗
|
725735-28-4
|
|
Maslimomab
|
马司莫单抗
|
127757-92-0
|
|
Altumomab
|
阿妥莫单抗
|
156586-92-4
|
|
Vepalimomab
|
维帕莫单抗
|
195158-85-1
|
|
Nerelimomab
|
奈瑞莫单抗
|
162774-06-3
|
|
Minretumomab
|
明瑞莫单抗
|
195189-17-4
|
|
Bectumomab
|
贝妥莫单抗
|
158318-63-9
|
|
Morolimumab
|
莫罗木单抗
|
|
|
Rovelizumab
|
罗维珠单抗
|
339086-79-2
|
|
Mogamulizumab
|
莫格利组单抗
|
1159266-37-1
|
|
Faralimomab
|
法拉莫单抗
|
167816-91-3
|
|
Icrucumab
|
艾芦库单抗
|
1024603-92-6
|
|
Fulranumab
|
福拉奴单抗
|
902141-80-4
|
|
Atinumab
|
阿替奴单抗
|
1226761-65-4
|
|
Carlumab
|
卡芦单抗
|
915404-94-3
|
|
Samalizumab
|
沙马组单抗
|
1073059-33-2
|
|
Enavatuzumab
|
依那妥组单抗
|
1062149-33-0
|
|
Etrolizumab
|
依曲利组单抗
|
1044758-60-2
|
|
Enokizumab
|
依诺凯组单抗
|
909875-08-7
|